Article metrics

Download PDFPDF

Original article
Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension study

 

Online download statistics by month:

Online download statistics by month: September 2019 to July 2022

AbstractFullPdf
Sep 2019527543178
Oct 2019477469169
Nov 201929629099
Dec 201922522180
Jan 202020520469
Feb 202022422078
Mar 2020227223294
Apr 202020119958
May 202018518578
Jun 202016516366
Jul 202019919496
Aug 202013913491
Sep 202016415580
Oct 2020222217136
Nov 202018217976
Dec 202015214965
Jan 202116616250
Feb 202113112358
Mar 202118017471
Apr 202115515266
May 202115914761
Jun 202112812265
Jul 202112712360
Aug 202113812960
Sep 202112712349
Oct 202114513878
Nov 2021817855
Dec 202110710045
Jan 2022827527
Feb 202214915359
Mar 202217216744
Apr 202212310958
May 202212011376
Jun 2022989032
Jul 20221038740
Total628161102767